Symbol Lookup

Sunday May 19, 2013 8:24 AM ET. Data delayed 15 minutes.
2.69
0.01 (0.37%)
Bid/Lots
2.66/35
Ask/Lots
2.69/3
Open/Prev Close
2.66/2.68
Day Range
2.66-2.76
52-Week Range
2.62-4.75
Vol/Avg Daily Vol
10.9K/37.8K
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
IMRIS Drops 9% Near 52-Week Low; Q1 Loss Unchanged from Year Ago, Sales Higher - Guides Q2
2:34PM ET on Friday May 03, 2013 by Midnight Trader
02:34 PM EDT, 05/03/2013 (MidnightTrader) -- IMRIS Inc. (IMRS) is down 9.3% to $2.78, near the stock's 52-week low, after the company late Thursday reported a Q1 loss of $0.18, unchanged from Q1 the prior year. Revenues were $8.1 million in the ...
IMRIS reports first quarter 2013 financial results
4:01PM ET on Thursday May 02, 2013 by CNW Group

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the first quarter of 2013. All figures are reported in US dollars. Revenues were $8.1 million in the quarter compared with $3.5 million in the first...

IMRIS reports first quarter 2013 financial results
4:01PM ET on Thursday May 02, 2013 by PR Newswire

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the first quarter of 2013. All figures are reported in US dollars. Revenues were $8.1 million in the quarter compared with $3.5 million in the first...

IMRIS establishes SYMBIS(TM) Surgical System Advisory Board
1:34PM ET on Wednesday May 01, 2013 by CNW Group

Three internationally prominent surgeons to consult on neurosurgical robot commercialization

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the establishment of the SYMBISTM Surgical System Advisory Boar...

IMRIS establishes SYMBIS™ Surgical System Advisory Board
1:34PM ET on Wednesday May 01, 2013 by PR Newswire

Three internationally prominent surgeons to consult on neurosurgical robot commercialization

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the establishment of the SYMBIS™ Surgical System Advisory Board...

Company Information

IMRIS Inc. (IMRIS) designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians. Designed to enable hospital's clinical application needs, the VISIUS Surgical Theatre can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality. IMRIS sells the VISIUS Surgical Theatres globally to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets. The VISIUS Surgical Theatre incorporates magnetic resonance imaging, CT and fluoroscopy into multi-purpose surgical suites to provide truly intra-operative imaging for specific medical applications.

CONTACT INFORMATION

Headquarters100, 1370 Sony Place
WINNIPEG, MB, Canada R3T 1N5
Phone204-480-7070
Fax204-480-7071

EXECUTIVE OFFICERS

Chairman of the Board, Chief Executive OfficerH. David Graves
President, Chief Operating OfficerJay Miller
Chief Financial Officer, Executive Vice President - Finance & Administration, SecretaryKelly McNeill
Executive Vice President - Global SalesMark Reade
Executive Vice President - MarketingAmy Boyle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • Standard & Poor's Stock Report

    Standard & Poor's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap--Beta--
Revenue (TTM)--EPS--
Shares Out.--Book Value--
Dividend Yield0.00%P/E--
Annual Dividend Rate$0.00Price/Sales (TTM)--
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin--

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample